EBF3 and melanoma: When melanoma cell lines were treated with a demethylating agent, decitabine, reduction in EBF3 gene expression was associated with demethylation of the EBF3 promoter DMF, supporting the notion that reducing methylation of the EBF3 promoter causes reduction of the corresponding EBF3 mRNA levels.